Stock Expert AI

VHT (VHT) ETF Analysis | Stock Expert AI

VHT offers exposure to the health care sector, holding just 10 stocks. Its top holding is Eli Lilly and Co (LLY) at 12.70%. With a 1.03% dividend yield and a beta of 0.73, VHT provides a focused, relatively low-volatility approach to investing in health care. Past performance does not guarantee future results.

VHT (VHT) ETF — Price, Holdings & Analysis

VHT offers exposure to the health care sector, holding just 10 stocks. Its top holding is Eli Lilly and Co (LLY) at 12.70%. With a 1.03% dividend yield and a beta of 0.73, VHT provides a focused, relatively low-volatility approach to investing in health care. Past performance does not guarantee future results.

ETF Overview

VHT provides targeted exposure to the health care sector through a concentrated portfolio of just 10 holdings. The fund's strategy focuses on large-cap companies, with Eli Lilly and Co (LLY) representing the largest allocation at 12.70%, followed by Johnson & Johnson (JNJ) at 8.22% and AbbVie Inc (ABBV) at 6.00%. This concentrated approach allows investors to gain specific exposure to leading companies within the pharmaceutical, biotechnology, and health care equipment industries. The fund's selection methodology prioritizes established companies with significant market capitalization, potentially offering stability compared to broader health care ETFs. VHT may appeal to investors seeking a focused approach to health care investing, but its concentrated nature warrants careful consideration. Past performance does not guarantee future results.

Risk Metrics

VHT's concentrated portfolio of 10 holdings introduces a higher level of concentration risk compared to more diversified health care ETFs. The top holding, Eli Lilly and Co (LLY), accounts for 12.70% of the fund, meaning its performance significantly impacts VHT's overall returns. The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations. Investors should also consider the potential impact of regulatory changes and drug pricing pressures on the pharmaceutical and biotechnology industries, which could disproportionately affect VHT due to its sector focus. Past performance does not guarantee future results.

Top Holdings

Dividend Yield

1.03%

Risk Metrics

  • Beta: 0.73

Questions & Answers

What is VHT and what does it track?

VHT is an exchange-traded fund (ETF) that provides focused exposure to the health care sector. Unlike broader health care ETFs, VHT holds a very concentrated portfolio of just 10 stocks. The fund's top holdings include companies like Eli Lilly and Co (LLY), Johnson & Johnson (JNJ), and AbbVie Inc (ABBV). This concentrated approach allows investors to target specific companies within the health care industry, but it also introduces a higher level of concentration risk. Past performance does not guarantee future results.

What is the expense ratio for VHT?

While specific expense ratio data is unavailable, it's important to consider expense ratios when evaluating ETFs. Expense ratios represent the annual cost of owning the ETF, expressed as a percentage of the fund's assets. Lower expense ratios generally lead to better long-term returns, as less of the fund's assets are used to cover operating expenses. Investors should compare VHT's expense ratio to those of similar health care ETFs to determine its cost-effectiveness. Past performance does not guarantee future results.

What are the top holdings in VHT?

VHT's top holdings are heavily weighted towards leading companies in the pharmaceutical and health care sectors. As of 2026-03-15, the top three holdings are Eli Lilly and Co (LLY) at 12.70%, Johnson & Johnson (JNJ) at 8.22%, and AbbVie Inc (ABBV) at 6.00%. Other significant holdings include Merck & Co Inc (MRK) at 4.19% and UnitedHealth Group Inc (UNH) at 3.96%. These top holdings collectively represent a significant portion of the fund's assets, highlighting the concentrated nature of VHT's portfolio. Past performance does not guarantee future results.

Is VHT a good long-term investment?

Whether VHT is a suitable long-term investment depends on an individual investor's risk tolerance, investment objectives, and time horizon. VHT offers focused exposure to the health care sector through a concentrated portfolio of 10 stocks. The fund's beta of 0.73 suggests lower volatility compared to the broader market, but the concentrated nature of the holdings could still lead to significant price fluctuations. Investors should carefully consider the potential risks and rewards of investing in VHT before making a decision. Past performance does not guarantee future results.

How does VHT compare to similar ETFs?

VHT distinguishes itself from other health care ETFs through its highly concentrated portfolio of just 10 holdings. While specific expense ratio and AUM data are unavailable, the fund's strategy of focusing on a small number of large-cap companies sets it apart from more diversified health care ETFs. Investors seeking targeted exposure to leading companies within the pharmaceutical and biotechnology industries may find VHT appealing. However, the fund's concentrated nature also introduces a higher level of concentration risk compared to its peers. Past performance does not guarantee future results.

Does VHT pay dividends?

Yes, VHT distributes dividends to its shareholders. As of 2026-03-15, VHT has a dividend yield of 1.03%. The dividend yield represents the annual dividend income received from the fund, expressed as a percentage of the fund's net asset value. Investors seeking income from their investments may find VHT's dividend yield attractive, but it's important to note that dividend yields can fluctuate over time. Past performance does not guarantee future results.